GlassScriptPhysician profile
Joyce Wilson
NPI 1093925703
$5,080.70
in general payments reported to CMS, 2019-2025
33 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,793 · 2020: $127 · 2021: $389 · 2022: $1,417 · 2023: $348 · 2024: $488 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,354.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $2,728.24 | 2019-2025 | |
| Depuy Synthes Sales INC. | $559.86 | 2019-2025 | Na, Hammerlock, Orthocord |
| Endo Pharmaceuticals INC. | $200.55 | 2019-2023 | Xiaflex |
| Janssen Biotech, INC. | $184.39 | 2022-2025 | Tremfya, Stelara |
| Vertex Pharmaceuticals Incorporated | $150.36 | 2024-2025 | |
| Axogen | $139.16 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Abbvie INC. | $135.71 | 2023-2024 | Qulipta, Vraylar |
| Lundbeck LLC | $125.82 | 2022-2024 | Vyepti |
| Sonex Health, INC. | $105.93 | 2021-2025 | Sx-One Microknife |
| Phathom Pharmaceuticals, INC. | $103.53 | 2025 | Voquezna |
| Stryker Corporation | $77.20 | 2024 | Iconix, Inspace, Champion Slingshot |
| Pacira Therapeutics, INC. | $62.04 | 2019-2021 | |
| Bioventus LLC | $54.68 | 2019-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Ermi LLC | $49.74 | 2023 | |
| Ferring Pharmaceuticals INC. | $41.29 | 2019-2025 | Euflexxa |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $39.29 | 2022 | |
| Amgen INC. | $31.10 | 2020 | |
| Organogenesis INC. | $29.74 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $29.23 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $27.86 | 2020-2021 | |
| Fidia Pharma USA INC. | $21.98 | 2024 | Hymovis |
| Heron Therapeutics, INC. | $21.49 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.20 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.55 | 2023 | Xifaxan |
| Pacira Pharmaceuticals Incorporated | $17.38 | 2025 | Exparel |
| Convatec INC. | $16.75 | 2019 | |
| Orthofix Medical, INC. | $16.45 | 2025 | Cervical-Stim |
| Assertio Therapeutics, INC. | $15.83 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.68 | 2019 | |
| Antares Pharma, INC. | $15.31 | 2024 | Xyosted |
| Endo USA, INC. | $13.66 | 2024 | Xiaflex |
| Horizon Therapeutics Plc | $12.70 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,140,961.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.